The Current Ratio of CStone Pharmaceuticals (2616.HK) is 1.56.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 1.56 |
| 2023-12-31 | 1.56 |
| 2022-12-31 | 1.32 |
| 2021-12-31 | 2.10 |
| 2020-12-31 | 4.91 |
| 2019-12-31 | 6.30 |
| 2018-12-31 | 1.45 |
| 2017-12-31 | 4.82 |
| 2016-12-31 | 13.94 |